OUR
Publications
Last updated July 22, 2024
PUBLICATIONS
Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis
Bre-Anne Fifield, John Vusich, Erika Haberfellner, Eran R Andrechek, Lisa A Porter
High-impact practices in cancer education and research: Undergraduate students' perceptions of skills and career development
Mohammad A Al Hakani, Edward A Grimmett, Eleftheria Laios, Jake Frank, Subidsa Srikantha, Kaila Wilson, Karen Metcalfe, Caroline Hamm, Lisa A Porter, Dora Cavallo-Medved
Evaluating and optimizing Acid-pH and Direct Lysis RNA extraction for SARS-CoV-2 RNA detection in whole saliva
Brayden LaBute , Jackie Fong , Farinaz Ziaee , Robert Gombar, Mathew Stover, Terry Beaudin, Maria Badalova, Qiudi Geng, Ryland Corchis-Scott, Ana Podadera, Kyle Lago, ZhenHuan Xu, Fievel Lim, Felix Chiu, Minghua Fu, Xiaofeng Nie, Yuanmin Wu, Corrina Quan, Caroline Hamm, R Michael McKay, Kenneth Ng, Lisa A Porter, Yufeng Tong
Presentation and Outcome of Patients with Multiple Myeloma (MM), Single Centre Experience from Windsor Essex Regional Cancer Centre
Dalia Kashash, Eric McArthur, Caroline Hamm, Rasna Gupta, Sindu Kanjeekal, Mohammad Jarrar, Lisa A Porter, John W Hudson, Adam Renaud, Indryas Woldie
E-learning and research experience exchange in the online setting of student peer mentor network during COVID-19 pandemic and beyond: A laboratory case study
Dorota Lubanska, Sami Alrashed, Lia Oschanney, Alan Cieslukowski, Ali Nadi, Philip Habashy, Adam Renaud, Antonio Roye-Azar, Mohamed Soliman, Kadila Adili, Allison Baker, Maliha Baseet, Amy Llancari, Aiden Mitrevski, Sahar Mouawad, Kim Nguyen, Alexandra Sorge, Katie Zuccato, Emmanuel Boujeke, Jason Cala, Stephanie Dinescu, Marissa Ho, Almas Khan, Deya’a Almasri, Daniel Dunn, Hasan Ghafoor, Eddie Grimmett, Elie Mouawad, Ria Patel, Milica Paunic, Depen Sharma, Tiana Visconti, Vanessa Vuong, Lisa A Porter
Biochem Mol Biol Educ 2024 Jan-Feb;52(1):93-105. doi: 10.1002/bmb.21792. Epub 2023 Oct 93
Actionable wastewater surveillance: application to a university residence hall during the transition between Delta and Omicron resurgences of COVID-19
Ryland Corchis-Scott , Qiudi Geng , Abdul Monem Al Riahi , Amr Labak , Ana Podadera , Kenneth K S Ng , Lisa A Porter , Yufeng Tong , Jess C Dixon , Sherri Lynne Menard , Rajesh Seth , R Michael McKay
Front. Public Health, 17 May 2023
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 11 – 2023 | doi.org/10.3389/fpubh.2023.1139423
Tuberin levels during cellular differentiation in brain development
Elizabeth Fidalgo da Silva, Bashaer Abu Khatir+, Christopher Drouillard+, Isabelle Hinch+, Gordon Omar Davis, Mariam Sameem, Rutu Patel, Jackie Fong, Dorota Lubanska, and Lisa A. Porter.
+ Contributed equally, listed in alphabetical order
Differentiation 2023 March–April Vol 130 Pages 43-50 doi.org/10.1016/j.diff.2022.12.004
Frequently used antiemetic agent dexamethasone enhances the metastatic behaviour of select breast cancer cells
Crozier M, Tubman J, Fifield BA, Ferraiuolo RM, Ritchie J, Zuccato K, Mailloux E, Sinha I, Hamm C, Porter LA.
PLoS One. 2022 Sep 15;17(9):e0274675. doi: 10.1371/journal.pone.0274675. eCollection 2022.PMID: 36107918
Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments
Ferraiuolo RM, Fifield BA, Hamm C, Porter LA.
Breast Cancer Res Treat. 2022 Nov;196(1):17-30. doi: 10.1007/s10549-022-06715-z. Epub 2022 Aug 27.PMID: 36029387
Dissecting the roles of the Tuberin protein in the subcellular localization of the G2/M Cyclin, Cyclin B1
A. Pillon, J. Dare-Shih, J. Fong, E. Fidalgo da Silva, and L. A. Porter
PLoS One 2022 Aug 10;17(8):e0272741. doi: 10.1371/journal.pone.0272741. – NSERC funded
Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles
Lubanska D, Alrashed S, Mason GT, Nadeem F, Awada A, DiPasquale M, Sorge A, Malik A, Kojic M, Soliman MAR, deCarvalho AC, Shamisa A, Kulkarni S, Marquardt D, Porter LA, Rondeau-Gagné S.
Sci Rep. 2022 Jul 15;12(1):12078. doi: 10.1038/s41598-022-15244-0.PMID: 35840697
Fitted filtration efficiency and breathability of 2-ply cotton masks: Identification of cotton consumer categories acceptable for home-made cloth mask construction
Drouillard KG, Tomkins A, Lackie S, Laengert S, Baker A, Clase CM, De Lannoy CF, Cavallo-Medved D, Porter LA, Rudman RS.
PLoS One. 2022 Mar 22;17(3):e0264090. doi: 10.1371/journal.pone.0264090. eCollection 2022.PMID: 35316263
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer
Hamm C, Fifield BA, Kay A, Kulkarni S, Gupta R, Mathews J, Ferraiuolo RM, Al-Wahsh H, Mailloux E, Hussein A, Porter LA.
Med Oncol. 2022 Feb 1;39(4):49. doi: 10.1007/s12032-021-01637-0.PMID: 35103812
Clinical Trial
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
Bakht MK, Hayward JJ, Shahbazi-Raz F, Skubal M, Tamura R, Stringer KF, Meister D, Venkadakrishnan VB, Xue H, Pillon A, Stover M, Tronchin A, Fifield BA, Mader L, Ku SY, Cheon GJ, Kang KW, Wang Y, Dong X, Beltran H, Grimm J, Porter LA, Trant JF.
Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2025710119.
doi: 10.1073/pnas.2025710119.PMID: 35064078
Beyond Protein Synthesis; The Multifaceted Roles of Tuberin in Cell Cycle Regulation
E. Fidalgo da Silva, J. Fong, A. Roye-Azar, A. Nadi, C. Drouillard, A. Pillon and L. A. Porter
Front. Cell Dev. Biol., 14 January 2022 | https://doi.org/10.3389/fcell.2021.806521 – NSERC funded
A retrospective single center study investigating the clinical significance of grade in triple negative breast cancer.
S. Upneja, A. Hussein, D. Moudgil, S. Kulkarni, R. Gupta, A. Kay, LA. Porter, B. Fifield, R. Ferraiuolo and C. Hamm. (2022)
Cancer Studies and Therapeutics (#2002-7184 in press).
Barriers to translational research in Windsor Ontario: A survey of clinical care providers and health researchers
JB Senecal, K Metcalfe, K Wilson, I Woldie and LA. Porter.
Journal of Translational Medicine. 2021 Nov; 19(1):479.
[PDF]
Averting an Outbreak of SARS-CoV-2 in a University Residence Hall through Wastewater Surveillance.
Corchis-Scott R, Geng Q, Seth R, Ray R, Beg M, Biswas N, Charron L, Drouillard KD, D’Souza R, Heath DD, Houser C, Lawal F, McGinlay J, Menard SL, Porter LA, Rawlings D, Scholl ML, Siu KWM, Tong Y, Weisener CG, Wilhelm SW, McKay RML.
Microbiol Spectr. 2021 Oct 6:e0079221. doi: 10.1128/Spectrum.00792-21. Online ahead of print.PMID: 34612693 Free article.
The cyclin-like protein SPY1 overrides reprogramming induced senescence through EZH2 mediated H3K27me3.
Lubanska D, Qemo I, Byrne M, Matthews KN, Fifield BA, Brown J, da Silva EF, Porter LA.Stem Cells. 2021 Sep 6. doi: 10.1002/stem.3453. Online ahead of print.PMID: 34486784
Differential expression of glucose transporters and hexokinases in prostate cancer with a neuroendocrine gene signature: a mechanistic perspective for FDG imaging of PSMA-suppressed tumors
Bakht MK, Lovnicki JM, Tubman J, Stringer KF, Chiaramonte J, Reynolds MR, Derecichei I, Ferraiuolo RM, Fifield BA, Lubanska D, Oh SW, Cheon GJ, Kwak C, Jeong CW, Kang KW, Trant JF, Morrissey C, Coleman I, Wang Y, Ahmadzadehfar H, Dong X Porter LA
J Nucl Med 2020; 61:904–910 DOI: 10.2967/jnumed.119.231068. Featured Article June 2020
[PDF 2.0 MB]
The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis
Fifield BA, Qemo I, Kirou E, Cardiff RD, Porter LA
Breast Cancer Res. 2019 Dec 11;21(1):140. doi: 10.1186/s13058-019-1211-3. [Epub ahead of print]
[PDF 9.0 MB]
Cyclin-Like Proteins Tip Regenerative Balance in the Liver to Favour Cancer Formation
Fifield BA, Talia J, Stoyanovich C, Elliott MJ, Bakht MK, Basilious A, Samsoondar JP, Curtis M, Stringer KF, Porter LA Carcinogenesis 2020 Jul 10;41(6):850-862.
[PDF 2.0 MB]
Neuro‐ and hepatic toxicological profile of (S)‐2,4‐diaminobutanoic acid in embryonic, adolescent and adult zebrafish
Ferraiuolo RM, Meister D, Leckie D, Dashti M, Franke J, Porter LA , Trant JF
J Appl Toxicol. 2019 Aug 6. doi: 10.1002/jat.3840. [Epub ahead of print]
[PDF 1.0 MB]
Transcriptomics Signature from Next-Generation Sequencing Data Reveals New Transcriptomic Biomarkers Related to Prostate Cancer
Alkhateeb A, Rezaeian I, Singireddy S, Cavallo-Medved D, Porter LA , Rueda L
Cancer Inform. 2019 Mar 13;18:1176935119835522. doi: 10.1177/1176935119835522. eCollection
[PDF 1.0 MB]
The Tuberin and Cyclin B1 complex functions as a novel G2/M sensor of serum conditions and Akt signaling
Fidalgo da Silva E, Botsford S, Dare-Shih J, Hanna MA, Porter LA
PLoS One. 2019 Jan 10;14(1):e0210612. doi: 10.1371/journal.pone.0210612. eCollection 2019
[PDF 1.4 MB]
Cell cycle dynamics in glioma cancer stem cells
Qemo I, Porter LA
Methods Mol Biol. 2019;1869:117-126. doi: 10.1007/978-1-4939-8805-1_11
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
Bakht MK, Derecichei I, Li Y, Ferraiuolo RM, Dunning M, Oh SW, Hussein A, Youn H, Stringer KF, Jeong CW, Cheon GJ, Kwak C, Kang KW, Lamb AD, Wang Y, Dong X, Porter LA
Endocr Relat Cancer. 2018 Nov 23;26(2):131-146. doi: 10.1530/ERC-18-0226 Editor’s Choice – Paper of 2019
[PDF 6.3 MB]
Structural basis of divergent cyclin‐dependent kinase activation by Spy1/RINGO proteins
Denise A McGrath, Bre‐Anne Fifield, Aimee H Marceau, Sarvind Tripathi, Lisa A. Porter, Seth M Rubin
The EMBO Journal (2017). DOI 10.15252/embj.201796905
[PDF 2.0 MB]
An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomics, Interactomics and Transcriptomics Data
F Firoozbakht, I Rezaeian, M D’agnilloz, LA Porter, L Rueda and A Ngom.
Journal of Computational Biology 2017 24(8):756-766.
[PDF]
Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
Dorota Lubanska, Lisa A. Porter
Drugs R D (2017). doi:10.1007/s40268-017-0180-1
[PDF 2.0 MB]
The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance
Rosa-Maria Ferraiuolo, Janice Tubman, Indrajit Sinha, Caroline Hamm, Lisa Ann Porter
Oncotarget (2017) DOI: 10.18632/oncotarget.15578
[PDF 2.0 MB]
The potential roles of radionanomedicine and radioexosomic in prostate cancer research and treatment.
Martin K. Bakht, So Won Oh, Do Won Hwang, Yun-Sang Lee, Hyewon Youn, Lisa A. Porter, Gi Jeong Cheon, Cheol Kwak, Dong Soo Lee, Keon Wook Kang.
Curr Pharm Des. 2017 Feb 16. doi: 10.2174/1381612823666170216122412.
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment
Zainab A. Bazzi, Jennifer Balun, Dora Cavallo-Medved, Lisa A. Porter, Michael B. Boffa
Clin Exp Metastasis (2017) 34: 155. doi:10.1007/s10585-017-9837-y
[PDF 2.0 MB]
TAFIa is a Novel Inhibitor of Tumour Angiogenesis in Breast Cancer.
B Balun, ZA Bazzi, D Cavallo-Medved, LA Porter and MB Boffa.
BMC Cancer 2016 24 16(1):328. Funded by S4H (Boffa – PI).
[PDF 2.0 MB]
A Model used to Detect Differential Splice Junctions as Biomarkers in Prostate Cancer from RNA-seq Data.
I Rezaeian, A Tavakoli, D Cavallo-Medved, LA Porter, L Rueda.
Journal of Biomedical Informatics 2016 60:422-30. Funded by S4H (Rueda – PI).
[PDF 1.6 MB]
Direct Interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.
Mohammad Al Sorkhy, Bre-Anne Fifield, Dorothy Myers, Lisa A Porter.
Cell Cycle 2016 15 (1): 128-136 Topic of Editorial review. Dewhurst and Kaldis.
[PDF 1.0 MB]
Derivation of a novel G2 reporter system.
Elizabeth Fidalgo da Silva, Sabrina Botsford, Lisa A Porter.
Cytotechnology 2016 (1): 19 – 24
[PDF 0.9 MB]
Sodium salicylate reduces the level of GABAB receptors in the rat's inferior colliculus.
S Butt, F Ashraf, Lisa A Porter, H Zhang.
Neuroscience. 2016 Jan 4.
doi:10.1016/j.neuroscience.2015.12.021
PMID: 26705739
Paclitaxel-induced transcriptional regulation of Fas signaling pathway is antagonized by dexamethasone.
Martin Crozier, Lisa A Porter.
Breast Cancer Res. Treat. 2015 Oct 13. [Epub ahead of print]
PMID: 26463651
[PDF 1.1MB]
Effect of media on biofilter performance following ozonation of secondary treated municipal wastewater effluent: Sand vs. GAC.
MJ Reaume, R Seth, KN McPhedran, E Fidalgo da Silva and LA Porter.
Ozone: Science & Engineering 2015 37(2): 143-153. Funded by NSERC
[PDF 395 KB]
Atypical Cell Cycle Control over Neural Cell Fate.
Dorota Lubanska, Lisa A Porter.
Cell Cycle 2014 13 (19): 2987-8 ISI Impact – 5.423. Funded by CCSRI. PMID:25486555
[PDF 38KB]
The atypical cell cycle regulator Spy1 suppresses differentiation of the neuroblastoma stem cell population.
Dorota Lubanska, Lisa A Porter.
Oncoscience 2014 1 (5): 336–348 –Inaugural edition; cover selection
[PDF 2MB]
- Commented on: Podkowa M, Irwin MS. (2014) Oncotarget. 5(15):5848-
9. Editorial: Spy’ing on Differentiation in Neuroblastoma. PMID: 25109839 - Commented on: Bisteau X, Kaldis P. Oncotarget. (2014) Aug 30;5(16):6554-5. Editorial : Spy1/SpeedyA accelerates neuroblastoma. PMID: 25216512
- Commented on: Parvez Vora, Chitra Venugopal and Sheila K. Singh (2014) Oncotarget 5(22): 11014-11016 Revealed: The spy who regulates neuroblastoma stem cells.
The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma.
Dorota Lubanska, Brenna A Market-Velker, Ana C deCarvalho, Tom Mikkelsen, Elizabeth Fidalgo da Silva, Lisa A Porter.
Cancer Cell 2014 25 (1): 64–76
doi: http://dx.doi.org/10.1016/j.ccr.2013.12.006
Highlighted in Cancer Discovery 2014 4: OF11 doi:10.1158/2159-8290.CD-RW2014-025
[PDF 3.1MB]
- Highlighted in Cancer Discovery March 2014 doi:10.1158/2159-8290.CD-
RW2014-025. - Commented on: Parry PV and Engh JA Editorial Neurosurgery. (2014) Jun;74(6):N18-9. doi: 10.1227/01.neu.0000450235.
91492.8f PMID: 24836103 - Recommended by F1000Prime.
- Highlighted in Cancer Research (2014) 74:977.
The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.
Mohammad Al Sorkhy, Rosa-Maria Ferraiuolo, Espanta Jalili, Agnes Malysa, Andreea R Fratiloiu, Bonnie F Sloane, Lisa A Porter.
BMC Cancer 2012 25 (45)
doi:10.1186/1471-2407-12-45
[PDF 4.6MB]
pH effects on bio-permeability of natural rubber latex polymers.
Janice Tubman, Jiamila Maimaiti, Maher El Masri, Susan Fox-Wasylyshyn, Debbie Kane, Trinh TX Nguyen, Eleanor Maticka-Tyndale, Lisa A Porter.
American Journal of Biomedical Sciences 2011 3 (4): 292–300
doi: 10.5099/aj110400292
[PDF 391KB]
The tumor suppressor tuberin regulates mitotic onset through the cellular localization of cyclin B1.
Elizabeth Fidalgo da Silva, Shora B Ansari, Jiamila Maimaiti, Elizabeth A Barnes, Monica Kong-Beltran, Daniel J Donoghue, Lisa A Porter.
Cell Cycle 2011 10 (18): 3129–39
doi: 10.4161/cc.10.18.17296
[PDF 3.4MB]
The level and distribution of the GABA(B)R2 receptor subunit in the rat's central auditory system.
Lena Jamal , Hao Zhang, Paul G Finlayson , Lisa A Porter, Huiming Zhang.
Neuroscience 2011 181 (5): 243–56
doi: http://dx.doi.org/10.1016/j.neuroscience.2011.02.050
The cyclin-dependant kinase activator, Spy1A, is targeted for degradation by the ubiquitin ligase NEDD4.
Mohammad Al Sorkhy, Ryan Craig, Brenna Market, Ryan Ard, Lisa A Porter.
Journal of Biological Chemistry 2009 284 (5): 2617–27
doi:10.1074/jbc.M804847200
[PDF 1.4MB]
The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.
Azadeh Golipour, Dorothy Myers, Tiffany Seagroves, Daniel Murphy, Gerard I Evan, Daniel J Donoghue, Roger A Moorehead, Lisa A Porter.
Cancer Research 2008 68 (10): 3591–3600
doi: 10.1158/0008-5472.CAN-07-6453
[PDF 852KB]
Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27.
Christopher W McAndrew, Randy F Gastwirt, April N Meyer, Lisa A Porter, Daniel J Donoghue.
Cell Cycle 2007 6 (15): 1937-45
doi: 10.4161/cc.6.15.4520
[PDF 913KB]
Spy1 interacts with p27Kip1 to allow G1/S progression.
Lisa A Porter, Monica Kong-Beltran, Daniel J Donoghue.
Molecular Biology of the Cell 2003 14 (9): 3664-74
doi: 10.1091/mbc.E02-12-0820
[PDF 455KB]
Human Spy1 promotes survival of mammalian cells following DNA damage.
Elizabeth A Barnes, Lisa A Porter, Jean-Luc Lenormand, Ryan W Dellinger, Daniel J Donoghue.
Cancer Research 2003 63 (13): 3701–07
[PDF 283KB]
Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis.
Lisa A Porter, Howard Cukier, Jonathan M Lee.
Blood 2003 101 (5): 1928–33
doi: 10.1182/blood-2002-04-1103
[PDF 680KB]
Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer.
Nisha Anand, Sabita Murthy, Gudrun Amann, Meredith Wernick, Lisa A Porter, I Howard Cukier, Colin Collins, Joe W Gray, Joachim Diebold, Doug J Demetrick, Jonathan M Lee.
Nature Genetics 2002 31 (3): 301-5
doi:10.1038/ng904
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
Lisa A Porter, Ryan W Dellinger, John A Tynan, Elizabeth A Barnes, Monica Kong, Jean-Luc Lenormand, Daniel J Donoghue.
Journal of Cell Biology 2002 157 (3): 357–66
doi: 10.1083/jcb.200109045
[PDF 360KB]
alpha-, beta-, and gamma-Tubulin polymerization in response to DNA damage.
Lisa A Porter & Jonathan M Lee.
Experimental Cell Research 2001 270 (2): 151–8
doi: http://dx.doi.org/10.1006/excr.2001.5322
Abundance of cyclin B1 regulates gamma-radiation-induced apoptosis.
Lisa A Porter, Gurmit Singh, Jonathan M Lee.
Blood 2000 95 (8): 2645–50
[PDF 184KB]
FOLLOW PORTER LAB ON TWITTER
@L_Porterlabrats
Copyright © 2021 Porter Lab